Containment Care Units for Managing Patients with Highly Hazardous Infectious Diseases: A Concept Whose Time Has Come

Journal of Infectious Diseases

Volumn 214, Issue , 2016, Pages S137-S141

  Kortepeter, Mark G ^a   Kwon, Elena H ^b   Hewlett, Angela L ^c,e   Smith, Philip W ^d,e   Cieslak, Theodore J ^d,e  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c Division of Infectious Diseases Department of Medicine   (United States)

^d Department of Epidemiology   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Biocontainment patient care unit; Containment care; Ebola; Hazardous; Infectious disease; Isolation; Lassa; Marburg; Quarantine; Viral hemorrhagic fever

Indexed keywords

ACCREDITATION; ARTICLE; BIOSAFETY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; GOVERNMENT REGULATION; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL; LASSA VIRUS; MONKEYPOX; NONHUMAN; PATIENT CARE; PATIENT TRANSPORT; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; REASSURANCE; SEVERE ACUTE RESPIRATORY SYNDROME; UNITED STATES; VIRUS INFECTION; VIRUS TRANSMISSION; ZAIRE EBOLAVIRUS; ANIMAL; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HAZARDOUS WASTE; HEMORRHAGIC FEVER, EBOLA; HEMORRHAGIC FEVERS, VIRAL; LABORATORY; QUARANTINE; VIROLOGY;

ANIMALS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; CONTAINMENT OF BIOHAZARDS; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; HEMORRHAGIC FEVERS, VIRAL; HUMANS; LABORATORIES; QUARANTINE; UNITED STATES;

EID: 84990985640     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw292     Document Type: Article

References (34)

1. Tucker JB, Mahan ER. President Nixon's decision to renounce the U.S. offensive biological weapons program.Washington, DC: National Defense University Press, 2009.
2. Crawford DH. The invisible enemy: a natural history of viruses. New York, NY: Oxford University Press, 2000.
3. Covert NM. Cutting edge: a history of Fort Detrick, Maryland. 3rd ed. Fort Detrick, MD: Public Affairs Office, Headquarters U.S. Army Garrison, 1997:79.
4. Hill EE, McKee KT. Isolation and biocontainment of patients with highly hazardous infectious diseases. J Army Medical Dept 1991:10-4.
5. Cieslak TJ, Christopher GW, Eitzen EM. The slammer: isolation and biocontainment of patients exposed to biosafety level 4 pathogens. Clin Infect Dis 1999; 29:1083.
6. Kortepeter MG, Martin JW, Rusnak JM, et al. Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit. Emerg Infect Dis 2008; 14:881-7.
7. Reynolds G. Why were doctors afraid to treat Rebecca McLester? New York Times 18 April 2004.
8. Smith PW, Anderson AO, Christopher GW, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: A consensus statement. Biosecur Bioterror 2006; 4:351-65.
9. Department of Health and Human Services. Biosafety in microbiological and biomedical laboratories. 5th ed. HHS publication 21-1112. Washington, DC: Government Printing Office, 2009.
10. Trexler P, Spiers A, Gaya H. Plastic isolators for treatment of acute leukemia patients under germ-free conditions. Brit Med J 1975; 4:549-52.
11. Trexler P, Emond R, Evans B. Negative-pressure plastic isolator for patients with dangerous infections. Brit Med J 1977; 2:559-61.
12. Pigott DC. Hemorrhagic fever viruses. Crit Care Clin 2005; 21:765-83.
13. Centers for Disease Control and Prevention. Recommendations for initial management of suspected or confirmed cases of Lassa fever. MMWR Morb Mortal Wkly Rep 1980; 28:1S-12.
14. Centers for Disease Control and Prevention. Viral hemorrhagic fever: initial management of suspected and confirmed cases. MMWR Morb Mortal Wkly Rep 1983; 32:27S-38.
15. Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep 1988; 37:1-16.
16. Centers for Disease Control and Prevention. Update: management of patients with suspected viral hemorrhagic fever-United States. MMWR Morb Mortal Wkly Rep 1995; 44:475-9.
17. Centers for Disease Control and Prevention. Interim guidance for managing patients with suspected viral hemorrhagic fever in U.S. hospitals, May 19, 2005. http://cdc.gov/vhf/ebola/pdf/vhf-interim-guidance.pdf. Accessed 30 July 2016.
18. Centers for Disease Control and Prevention. Infection prevention and control recommendations 2014. http://www.cdc.gov/vhf/ebola/hcp/infection-preventionand-control-recommendations.html. Accessed 4 August 2014.
19. Kobinger GP, Leung A, Neufeld J, et al. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011; 204:200-8.
20. Weingartl HM, Embury-Hyatt C, Nfon C, Leung A, Smith G, Kobinger G. Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012; 2:811.
21. Barrette RW, Metwally SA, Rowland JM, et al. Discovery of swine as a host for the Reston ebolavirus. Science 2009; 325:204-6.
22. Centers for Disease Control and Prevention. Guidance on personal protective equipment (PPE) to be used by healthcare workers during management of patients with confirmed Ebola or persons under investigation (PUIs) for Ebola who are clinically unstable or have bleeding, vomiting, or diarrhea in U.S. hospitals, including procedures for donning and doffing PPE. Updated 27 August 2015. http://www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance.html. Accessed 14 March 2015.
23. Borchert M, Mutyaba I, Van Kerkhove MD, et al. Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis 2011; 11:357.
24. World Health Organization. Health worker infections in Guinea, Liberia, and Sierra Leone: a preliminary report, 2015. http://www.who.int/csr/resources/publications/ebola/health-worker-infections/en/. Accessed 29 February 2016.
25. World Health Organization. Ebola health worker infections. http://www.who.int/features/ebola/health-care-worker/en/. Accessed 29 February 2016.
26. Osterholm MT, Moore KA, Kelley NS, et al. Transmission of Ebola viruses: what we know and what we do not know. MBio 2015; 6:e00137.
27. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41.
28. Sullivan NJ, Geisbert TW, Geisbert JB, et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 2003; 424:681-4.
29. Isakov A, Jamison A, MilesW, Ribner B. Safe management of patients with serious communicable diseases: recent experience with Ebola virus. Ann Intern Med 2014; 161:829-30.
30. Kortepeter MG, Smith PW, Hewlett A, Cieslak TJ. Caring for patients with Ebola: a challenge in any care facility. Ann Int Med 2015; 162:68-9.
31. Centers for Disease Control and Prevention. Interim guidance for US hospital preparedness for patients under investigation (PUIs) or with confirmed Ebola virus disease (EVD): a framework for a tiered approach. http://www.cdc.gov/vhf/ebola/healthcare-us/preparing/hospitals.html. Updated 28 August 2015. Accessed 29 February 2016.
32. Centers for Disease Control and Prevention. Hospital preparedness: a tiered approach. http://www.cdc.gov/vhf/ebola/healthcare-us/preparing/currenttreatment-centers.html. Updated 20 February 2015. Accessed 29 February 2016.
33. Herstein JJ, Biddinger PD, Kraft CS, et al. Current capabilities and capacity of Ebola treatment centers in the United States. Infect Control Hosp Epidemiol 2016; 37:313-8.
34. Brett-Major DM, Jacob ST, Jacquerioz FA, et al. Being ready to treat Ebola virus disease patients. Am J Trop Med Hyg 2015; 92:233-7.